Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fox

Showing results (941-950 of 1,012) with videos related to

Pageof 102
Sort By:
Journal of the American Academy of Dermatology|September 13, 2021
Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based studyDevon E McMahon, Carrie L Kovarik, William Damsky, et al.
Hemasphere|June 5, 2024
Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAndreas J M Ferreri, Gerald Illerhaus, Jeanette K Doorduijn, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2020
DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo modelsMichael C Johnston, Julie A Nicoll, Kelly M Redmond, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 16, 2011
Tuberculosis in HIV programmes in lower-income countries: practices and risk factorsL Fenner, M Forster, A Boulle, et al.
BMC Infectious Diseases|December 20, 2023
Associations of inter-annual rainfall decreases with subsequent HIV outcomes for persons with HIV on antiretroviral therapy in Southern Africa: a collaborative analysis of cohort studiesAdam Trickey, Leigh F Johnson, Fai Fung, et al.
British Journal of Cancer|March 30, 2016
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI gradeHidenori Toyoda, Paul B S Lai, James O'Beirne, et al.
Advances in Therapy|May 26, 2021
Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre CohortNicolas Martinez-Calle, Amy A Kirkwood, Maxine Lamb, et al.
European Journal of Dermatology : EJD|May 5, 2017
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designsMartine Bagot, Baktiar Hasan, Sean Whittaker, et al.
Transplantation|October 26, 2020
Real-world Outcomes With Rituximab-based Therapy for Posttransplant Lymphoproliferative Disease Arising After Solid Organ TransplantDavid M Burns, Katherine Clesham, Yan A Hodgson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2020
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trialP Grimison, A Mersiades, A Kirby, et al.
Pageof 102

Showing results (941-950 of 1,012) with videos related to

Sort By:
Pageof 102
Journal of the American Academy of Dermatology|September 13, 2021
Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based studyDevon E McMahon, Carrie L Kovarik, William Damsky, et al.
Hemasphere|June 5, 2024
Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAndreas J M Ferreri, Gerald Illerhaus, Jeanette K Doorduijn, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2020
DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo modelsMichael C Johnston, Julie A Nicoll, Kelly M Redmond, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 16, 2011
Tuberculosis in HIV programmes in lower-income countries: practices and risk factorsL Fenner, M Forster, A Boulle, et al.
BMC Infectious Diseases|December 20, 2023
Associations of inter-annual rainfall decreases with subsequent HIV outcomes for persons with HIV on antiretroviral therapy in Southern Africa: a collaborative analysis of cohort studiesAdam Trickey, Leigh F Johnson, Fai Fung, et al.
British Journal of Cancer|March 30, 2016
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI gradeHidenori Toyoda, Paul B S Lai, James O'Beirne, et al.
Advances in Therapy|May 26, 2021
Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre CohortNicolas Martinez-Calle, Amy A Kirkwood, Maxine Lamb, et al.
European Journal of Dermatology : EJD|May 5, 2017
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designsMartine Bagot, Baktiar Hasan, Sean Whittaker, et al.
Transplantation|October 26, 2020
Real-world Outcomes With Rituximab-based Therapy for Posttransplant Lymphoproliferative Disease Arising After Solid Organ TransplantDavid M Burns, Katherine Clesham, Yan A Hodgson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2020
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trialP Grimison, A Mersiades, A Kirby, et al.
Pageof 102